Q4 Revenue Grew 27% Year-Over-Year to Record $14.5 Million Q4 Operating Income of $1.9 Million; Adjusted EBITDA Increased by 53% to $2.3 Million, Reflecting Significant Operating Leverage  Full Year 2025 Revenue Increased by Approximately 27% YoY to $52.2 Million, and Net Income Increased by Approximately 161% YoY to $7.6 Million Remaining Performance Obligations Increased 43% to Approximately $70 Million Issuing 2026 Guidance: Expecting Revenue of $66 – $68 million (27% – 30% Growth), Operating Income of 13% – 14%, and Adjusted EBITDA of $12 – $14 Million (86% – 100% Growth) Conference Call to be Held Today at 8:30 AM ET BURLINGTON, Mass. and JERUSALEM, March 11, 2026 (GLOBE NEWSWIRE) —  BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive...

Completed Phase 1 pharmacokinetic (PK) clinical trial of denifanstat and resmetirom combination Phase 2 trial of denifanstat/resmetirom combination in F4 MASH patients planned to initiate in 2H 2026 Secured global, exclusive license to TAPI’s innovative forms of resmetirom active pharmaceutical ingredients (API) First-in-human Phase 1 clinical trial of FASN inhibitor TVB-3567 ongoing Positive topline results in open-label Phase 3 trial evaluating the long-term safety of denifanstat in patients with moderate to severe acne in China reported by Ascletis China’s National Medical Products Administration (NMPA) accepted Ascletis’ New Drug Application (NDA) for denifanstat for the treatment of moderate to severe acne SAN MATEO, Calif., March 11, 2026 (GLOBE NEWSWIRE) — Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical...

Initiation of confirmatory Phase 3 trial with roluperidone for negative symptoms of schizophrenia is planned for Q2 2026, with topline data anticipated in 2H 2027 BURLINGTON, Mass., March 11, 2026 (GLOBE NEWSWIRE) — Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today provided business updates and reported financial results for the fourth quarter and year ended December 31, 2025. Business Updates Strategic Financing On October 23, 2025, Minerva received $80.0 million in gross proceeds from a private placement, before deducting fees and other expenses. The financing included initial upfront funding of $80.0 million and up to an additional $80.0 million if all Tranche A warrants are exercised, subject to...

2025 Full Year Revenue of $180.5 Million, up 12% Year-over-Year; Adjusted EBITDA of $42.0 Million, up 23% Year-over-Year; Net Income of $20.2 Million, up 40% Year-over-Year Company Affirms 2026 Annual Guidance of $200 Million – $205 Million in Revenues and $50 Million – $53 Million of Adjusted EBITDA, Representing Double-Digit Organic Growth Generated $25.5 Million of Cash from Operations in 2025; as of December 31, 2025 had $75.5 Million of Available Cash Company Aims to Secure New Business Development and M&A Transactions to Accelerate Profitable Growth Company Adopted an Annual Cash Dividend Policy and Declares Cash Dividend of $0.25 Per Share (Totaling Approximately $14.4 Million) Conference Call and Live Webcast Today at 8:30am ETREHOVOT, Israel, and HOBOKEN, N.J., March 11, 2026 (GLOBE NEWSWIRE) — Kamada Ltd. (NASDAQ:...

Delivers 13th Consecutive Quarter of Gross Originations Growth Pending Merger Transaction with The Aaron’s Company and CCF Holdings LLC Expected to Create a Premier Omnichannel Platform for Nonprime Consumers   PLANO, Texas, March 11, 2026 (GLOBE NEWSWIRE) — Katapult Holdings, Inc. (“Katapult” or the “Company”) (NASDAQ: KPLT), an e-commerce-focused financial technology company, today reported its financial results for the fourth quarter ended December 31, 2025. “We made a lot of operating and financial progress during 2025 driven both by the strength of our product offering as well as our team’s dedication to growth and success,” said Orlando Zayas, CEO of Katapult. “During 2025 we achieved 17% gross originations growth, which was supported by a 45% increase in applications and a 25% increase in lease originations, illustrating...

Record financial performance in 2025 Further improvement of financial metrics expected in 2026 Share buyback program of up to 500 million euros in 2026 2025 key figures: all financial indicators at record highsRevenue of 4,796.8 million euros, up +5.5% at constant exchange rates (+3.8% on an organic basis) Adjusted EBITDA up 5.6% to 1,700.1 million euros Adjusted EBITDA margin at 35.4%, up 20 bps Adjusted EBIT up 4.6% to 766.6 million euros Adjusted EBIT margin stable at 16.0% of revenue Net income up 8.6% at 366.6 million euros Headline net income up 4.7% at 467.3 million euros Headline net income per share up 5.2% to 1.85 euros (on a fully diluted basis) Free cash flow at 358.6 million euros, up 3.5% Financial leverage ratio at 1.75x as of December 31, 2025, down 0.1x compared to December 31, 20242025 business highlightsStrong...

SINGAPORE, March 11, 2026 (GLOBE NEWSWIRE) — JOYY Inc. (NASDAQ: JOYY) (“JOYY” or the “Company”), a global technology company, today announced its unaudited financial results for the fourth quarter and full year of 2025. Fourth Quarter 2025 Financial Highlights1Net revenues were US$581.9 million, an increase of 5.9% from US$549.4 million in the corresponding period of 2024 and 7.7% from US$540.2 million in the third quarter of 2025.Live streaming revenues were US$394.4 million, compared with US$422.4 million in the corresponding period of 2024, representing an increase of 1.5% from US$388.5 million in the third quarter of 2025. Advertising revenues2 increased by 62.4% to US$145.4 million from US$89.6 million in the corresponding period of 2024 and by 29.3% from US$112.5 million in the third quarter of 2025. Other revenues increased...

EDMONTON, Alberta, March 10, 2026 (GLOBE NEWSWIRE) — Melcor Developments Ltd. (TSX: MRD), an Alberta-based real estate development and asset management company, today reported results for the fourth quarter and year ended December 31, 2025. The annual Management Discussion & Analysis (MD&A) and Condensed Interim Financial Statements are available on our website (www.melcor.ca) under Investors, or on SEDAR+ (www.sedarplus.ca). Timothy Melton, Melcor’s Executive Chair and Chief Executive Officer, commented: “2025 marks a milestone year for Melcor, with revenues exceeding $400 million and funds from operations exceeding $100 million, both for the first time in Melcor’s history. Importantly, this achievement was realized while maintaining a conservative balance sheet and a disciplined, long-term approach to value...

CALGARY, Alberta, March 10, 2026 (GLOBE NEWSWIRE) — Total Energy Services Inc. (“Total Energy” or the “Company”) (TSX:TOT) announces its consolidated financial results for the three months ended December 31, 2025. Financial Highlights ($000’s except per share data, unaudited)  Three months endedDecember 31   Year endedDecember 31    2025   2024 Change     2025   2024 ChangeRevenue $ 301,705 $ 246,816 22%     $ 1,064,732 $ 906,776 17%  Operating income   25,511   15,892 61%       93,240   79,842 17%  EBITDA(1)   56,279   40,565 39%       195,070   171,845 14%  Cashflow   47,269   43,413 9%       171,975   162,435 6%  Net income   23,727   10,102 135%       74,349   60,725 22%  Attributable to shareholders   23,636   10,116 134%       74,217   60,801 22%                         Per Share Data (Diluted)                      EBITDA(1) $ 1.50 $ 1.04 44%     $ 5.14 $ 4.33 19%  Cashflow $ 1.26 $ 1.12 13%     $ 4.53 $ 4.10 10%                         Attributable...

Reports full year revenues of $563.8 million and Adjusted EBITDAS of $30.6 million CALGARY, Alberta, March 10, 2026 (GLOBE NEWSWIRE) — FLINT Corp. (“FLINT” or the “Company”) (TSX: FLNT) today announced its results for the year ended December 31, 2025. All amounts are in Canadian dollars and expressed in millions of dollars unless otherwise noted. “EBITDAS” and “Adjusted EBITDAS” are not standard measures under IFRS. Please refer to the Advisory regarding Non-GAAP Financial Measures at the end of this press release for a description of these items and limitations of their use. “2025 delivered strong operational and strategic outcomes. Through disciplined execution, we improved gross profit and Adjusted EBITDAS margins over the prior year. We also completed our transformational Recapitalization Transaction, significantly...